Boston University School of Public Health

Lisa Sullivan has a PhD in Statistics and is Professor of Biostatistics and Chair of the Department of Biostatistics.  She teaches Elementary Biostatistics for MPH students and was instrumental in developing a minor program in public health which is open to undergraduate students in the BU College of Arts and Sciences. Lisa is the Principal Investigator of the Summer Institute for Training in Biostatistics which is designed to promote interest in the field of biostatistics and its many exciting career opportunities. The program ran for the first time in the summer of 2004. Lisa is co-author of a textbook entitled Introductory Applied Biostatistics, author of Essentials of Biostatistics in Public Health and Co-Editor-in-Chief of the Enclyclopedia of Clinical Trials.  She is the recipient of numerous teaching awards including the Norman A. Scotch award and the prestigious Metcalf Award, both for excellence in teaching at Boston University. Lisa is a statistician on the Framingham Heart Study working primarily in developing and disseminating cardiovascular risk functions. She is active in multidisciplinary research projects including a variety of projects in cardiovascular disease, a large epidemiological study to assess the association between alcohol exposure in pregnancy and sudden infant death syndrome (SIDS), studies to improve methods for prenatal diagnosis and a clinical trial to improve repetitive behaviors in children affected with autism.

Read stories about Lisa Sullivan:

• Sullivan Honored with ASPH/Pfizer Award for Teaching Excellence 
  
• Citalopram No Better Than Placebo for Children with Autism Spectrum Disorders, Study Finds

Elias PK, Elias MF, D'Agostino RB, Sullivan LM, Wilson PW and Wolf PA. Serum cholesterol and cognitive performance in the Framingham Heart Study original cohort: A prospective analysis. Psychosomatic Medicine, 2005; 67: 24-30.

Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundstrom J, Kannel WB, Levy D, D'Agostino RB. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Annals of Internal Medicine, 2005; 142: 393-402.

Wataganara T, Chen AY, LeShane ES, Sullivan LM, Borgatta L, Johnson KL, Bianchi DW. Elevated cell-free fetal DNA levels in maternal plasma following elective termination of pregnancy after 9 weeks of gestation. Clinical Chemistry, 2005; 51(1): 217-219.

Fox CS, Sullivan LM, D'Agostino Sr. RB, Wilson PW. Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality: the Framingham Heart Study. Diabetes Care, 2005; 27(3): 704-708.

Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 2005; 112(20): 3066-3072.

Nanchahal K, Morris JN, Sullivan LM, Wilson PF. Coronary heart disease risk in men and the epidemic of overweight and obesity. International Journal of Obesity, 2005; 29(3): 317-323.

Samet JH, Horton NJ, Meli S, Dukes K, Tripp T, Sullivan L, Freedberg KA. A Randomized Controlled Trial to Enhance Antiretroviral Therapy Adherence in Patients with a History of Alcohol Problems. Antiviral Therapy, 2005; 10(1): 83-93.

Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension, 2005; 45(1): 28-33.

Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L et al. The quad screen as a predictor of adverse pregnancy outcome. Obstetrics and Gynecology, 2005; 106: 260-267.

Elias MF, Sullivan LM, D'Agostino RB, Jacques PF, Selhub J, Elias PK, Au R, Seshadri S, Beiser A, Wolf PA. Homocysteine and cognitive performance in the Framingham Offspring Study: Age is important. American Journal of Epidemiology, 2005; 162(7): 644-653.

Rutter MK, Meigs, JB, Sullivan LM, D'Agostino RB, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham offspring study. Diabetes, 2005; 54: 3252-3257.

Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Obesity, diabetes and cognitive deficit: the Framingham Heart Study. Neurobiology of Aging 26S, 2005; S11-S16.

Goff DC, Sullivan LM, McEvoy J, Meyer J, Nasrallah H, Daumit G, Lamberti S, D'Agostino RB, Stroup S, Lieberman J. A comparison of ten-year cardiac risk estimates in Schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 2005; 45(1): 28-33.

Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino, RB, Benjamin EJ. Tension and anxiety and the prediction of the ten-year incidence of coronary heart disease, atrial fibrillation and total mortality: The Framingham Offspring Study. Psychosomatic Medicine, 2005; 67(5): 692-696.

McEvoy JP, Meyer JM, Goff DC, Nasrallah H, Davis SM, Sullivan L, Meltzer HY, Hsaio J, Stroup S, Leiberman JA. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 2005; 80(1): 19-32.

Kathiresan S, Otvos JD, Sullivan L, Keyes MJ, Scahefer EJ, Wilson PW, D'Agostino RB, Vasan RS, Robins SJ. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation, 2006; 113(1); 20-29.

Lundgren LM, Sullivan L, Amodeo M. How do treatment repeaters use the drug treatment system? An analysis of injection drug users in Massachusetts. Journal of Substance Abuse Research, 2006; 30(2): 121-128.

Meigs JB, O'Donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes, 2006; 55(2): 530-537.

Sullivan LM. Statistical Primer for Cardiovascular Research: Estimation from samples. Circulation, 2006; 114: 445-449.

Lumley MA, Zamerowski ST, Jackson L, Dukes K, & Sullivan L. Psychosocial correlates of pregnant women's attitudes toward prenatal maternal serum screening and invasive diagnostic testing: Beyond traditional risk status. Genetic Testing, 2006; 10(2): 131-138.

Louks EB, Sullivan LM, D'Agostino RB, Larson MG, Berkman LF, Benjamin EJ. Social networks and inflammatory markers in the Framingham Heart Study. Journal of Biosocial Science, 2006; 38(16): 835-842.

Najarian RM, Sullivan LM, Kannel WB, D'Agostino RB, Wolf PA. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Archives of Internal Medicine, 2006; 166(1): 106-111.

Elias MF, Sullivan LM, Elias PK, D'Agostino RB, Vasan RS, Seshadri S, Au R, Wolf PA, Benjamin EJ. Atrial fibrillation and cognitive performance decrement in the Framingham Offspring men. Journal of Stroke of Cerebrovascular Diseases, 2006; 15(5): 214-222.

Louks EB, Sullivan LM, Hayes LJ, D'Agostino RB, Larson MG, Vasan RS, Benjamin EJ, Berkman LF. Association of the educational level with inflammatory markers in the Framingham Offspring Study. Epidemiology, 2006; 163(7): 622-628.

Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. Journal of Clinical Endocrinology and Metabolism, 2006; 91(8): 2906-2916.

Healy AJ, Malone FD, Sullivan LM, Porter F, et al.. Early Access to Prenatal Care: Implications for Racial Disparity in Perinatal Mortality. Obstetrics and Gynecology, 2006; 107(3): 625-631.

Elias MF, Sullivan LM, Elias PK, D'Agostino RB, Wolf PA, Seshadri S, Au R, Benjamin EJ, Vasan RS. Left ventricular mass, blood pressure and lowered cognitive performance in the Framingham Offspring. Hypertension, 2007; 49: 439-445.

Dingra R, Sullivan LM, Vasan RS. Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community. Archives of Internal Medicine, 2007; 167: 879-885.

Wilson PF, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB. Prediction of incident Diabetes Mellitus in Middle-Aged Adults: The Framingham Offspring Study. Archives of Internal Medicine, 2007; 167: 1068-1074.

Ingelsson E, Sullivan LM, Murabito JM, Fox CS, et al. Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals with the Metabolic Syndrome and Diabetes. Diabetes, 2007; 1718-1726.

Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.  Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care, 2007; 30(5): 1219-25.

Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan LM, Keyes, MJ et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA, 2007; 298(7): 776-785.

 Dhingra R, Sullivan L, Jaques PF, Wang TJ et al. Soft Drink Consumption and Risk of Developing Cardio-Metabolic Risk Factors and the Metabolic Syndrome in Middle-aged Adults in the Community. Circulation, 2007; 116: 480-488.

 Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino RB, Benjamin EJ. Marital status, marital strain and the risk of coronary heart disease or total mortality: The Framingham Offspring study. Psychosomatic Medicine, 2007; 69(6): 509-513.

 Ingelsson E, Sullivan LM, Murabito JM, Fox CS, et al. The Burden and Prognostic Importance of Subclinical Cardiovascular Disease in Overweight and Obese Individuals. Circulation, 2007; 116(4): 375-384.

Belogolovkin V, Eddleman KA, Malone FD, Sullivan L, Ball RH, Nyberg DA, et al. The effect of low body mass index on the development of gestational hypertension and preeclampsia. Journal of Maternal-Fetal and Neonatal Medicine. 2007; 20(7): 509-513.

Guo W, Bigornia S, Xie W, McDonnell M, Clemente K, Leizerman I, Pirtskhalava T, Kirkland JL, Gokee N, Corkey C, Sullivan L, Apovian C. New scanning Electron Microscopic method for determination of adipocyte size in humans and mice. Obesity, 2007; 15(7): 1657-1665.

Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Archives of Internal Medicine. 2007; 167(10): 1068-1074.

Dolan S, Gross SJ, Merkatz IR, Faber V, Sullivan LM, et al. The contribution of birth defects to prematurity and low birthweight in a population-based screening study. Obstetrics and Gynecology. 2007; 110: 318-324.

Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Ramachandrun VS, Wilson PF, D'Agostino RB. LDL particle number and the risk of future cardiovascular disease in the Framingham Offspring Study - Implications for LDL management. Journal of Clinical Lipidology. 2007; 1: 583-592.

Kannel WB, Vasan RS, Keyes MJ, Sullivan LM, Robins SJ. Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort). American Journal of Cardiology. 2008; 101: 497-501.

Sullivan LM. Statistical Primer for Cardiovascular Research: Repeated measures. Circulation. 2008: 117: 1238-1243.

Rutter MK, Wilson PW, Sullivan LM, Fox CS, D'Agostino RB, Meigs J. Use of alternative thresholds defining insulin resistance to predict Incident Type 2 Diabetes and cardiovascular disease. Circulation. 2008; 117:1003-1009.

Lee JL, Kleinbaum D, Diener-West M, Grimley DM, Hellerstedt WL, Sullivan L, Aday LA and Riegelman R. Teaching excellence in public health: A call to action. Public Health Reports. 2008; 123: 405-407.